Welcome to Our Blog

Subscribe below to get free access to our latest newsletter and watch our product video

Patient-centric drug design could transform patients’ experience

Greater patient input into drug product design could significantly improve outcomes and save health systems millions, by...


( read )

Tags: "patient listening", Healthcare, Patient Experience,

Semalytix’ and Boehringer Ingelheim’s innovative social media study on the parental experience around Crohn’s disease wins EphMRA award

A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...


( read )

Tags: Semalytix, Pharma, PatientListening,

How Multilingual Text Analytics leverages Patient Centricity in Health Care

At Semalytix, we are committed to supporting pharmaceutical companies in their endeavors concerning patient-focused drug...


( read )

Tags: AI, Healthcare, Pharma,

Building Trust by Listening: A Priority During Lockdown

The behavior and responsiveness of all companies and brands during the coronavirus crisis will have a big impact on how they...


( read )

Tags: "patient listening", Healthcare, COVID19,

Leveraging Patient-Focused Drug Development by Social Media Patient Listening Studies
Philipp Cimiano (Chief Technology Officer)
Matthias Hartung (Chief Research Officer)
Jens Höwelkröger (Product Manager)

( read )

Tags: Semalytix, AI, Healthcare,

Are you listening? Patients will tell you what a good drug looks like.

Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...


( read )

Tags: Semalytix, "patient listening", "Health"

What the pharmaceutical industry can learn from online conversations about healthcare

People talk about everything online – including health. The pharmaceutical industry can pay attention. The start-up Semalytix...


( read )
White Paper: AI-Powered Real-World Evidence Generation

Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders

Executive Summary


( read )

Tags: Paper, Semalytix, AI

How machines can measure the real impact of new therapies

By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences


( read )

Tags: Semalytix

Semalytix’ Knowledge Graph featured at the Neo4J Meeting „GraphTalk: Health & Life Sciences“ in Basel

The knowledge graph developed by Semalytix comprises of millions of pharma-relevant entities modeling key knowledge about...


( read )

Tags: Semalytix